China’s Zhejiang Silk Road Fund backs $100m Series B for CMR Surgical

An attendee holds the hand of a humanoid robot named Pepper, developed by SoftBank Corp.’s Aldebaran Robotics unit, during a SoftBank developer’s workshop for students and robot enthusiasts in Tokyo, Japan, on Wednesday, March 4, 2015. Photographer: Akio Kon/Bloomberg

CMR Surgical Ltd, a British company developing a next-generation surgical robot, on Tuesday announced that it has closed a Series B funding round of $100 million from China’s Zhejiang Silk Road Fund and existing investors Escala Capital Investments, LGT, Cambridge Innovation Capital and Watrium.

Headquartered in Cambridge, UK, CMR Surgical is developing the next-generation universal robotic system, Versius, to make minimal access surgery universally accessible and affordable. About six million people undergo open surgery each year.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter